| Gregory Alan Wiener, MD, FACS | |
|
7447 W Talcott Ave, Ste 451, Chicago, IL 60631-3745 | |
| (773) 763-3990 | |
| (773) 763-6346 |
| Full Name | Gregory Alan Wiener |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 33 Years |
| Location | 7447 W Talcott Ave, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609969765 | NPI | - | NPPES |
| 1623188 | Other | IL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | (Illinois) | Primary |
| Entity Name | Gregory A Wiener Md Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154519023 PECOS PAC ID: 0941463178 Enrollment ID: O20120525000008 |
News Archive
Some patient subgroups see greater improvement after surgery for herniated spinal discs relative to nonoperative outcomes—notably including married patients whose symptoms are getting worse, reports a study in the January 15, 2012, issue of Spine.
A new indoor software tracking system conceived at the Henry Ford Innovations in Detroit for use in hospitals is being compared to GPS for its functionality.
Given Imaging Ltd., the global leader in patient-friendly GI diagnostic and monitoring solutions, today unveiled RAPID® pH review and analysis software for the Bravo® pH Monitoring System. This all-new software was designed to streamline pH monitoring workflow through simplified, easy-to-use screen layouts and intuitive software navigation.
Akorn, Inc., a niche generic pharmaceutical company, today reported that its Akorn-Strides LLC joint venture has entered into a purchase agreement with Pfizer Inc. to sell 16 Abbreviated New Drug Approvals (ANDAs) and 6 filed ANDAs. For its portion, Akorn, Inc. will receive $35 million in cash. Akorn-Strides LLC will continue to manufacture and distribute the approved products until April 30, 2011.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has completed enrollment in the first of two dose cohorts in its Phase 1 clinical trial of PV-10 for liver cancer, and that the therapy was very well tolerated by all three subjects treated, with substantial evidence of efficacy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Alan Wiener, MD, FACS 7447 W Talcott Ave, Ste 451, Chicago, IL 60631-3745 Ph: (773) 763-3990 | Gregory Alan Wiener, MD, FACS 7447 W Talcott Ave, Ste 451, Chicago, IL 60631-3745 Ph: (773) 763-3990 |
News Archive
Some patient subgroups see greater improvement after surgery for herniated spinal discs relative to nonoperative outcomes—notably including married patients whose symptoms are getting worse, reports a study in the January 15, 2012, issue of Spine.
A new indoor software tracking system conceived at the Henry Ford Innovations in Detroit for use in hospitals is being compared to GPS for its functionality.
Given Imaging Ltd., the global leader in patient-friendly GI diagnostic and monitoring solutions, today unveiled RAPID® pH review and analysis software for the Bravo® pH Monitoring System. This all-new software was designed to streamline pH monitoring workflow through simplified, easy-to-use screen layouts and intuitive software navigation.
Akorn, Inc., a niche generic pharmaceutical company, today reported that its Akorn-Strides LLC joint venture has entered into a purchase agreement with Pfizer Inc. to sell 16 Abbreviated New Drug Approvals (ANDAs) and 6 filed ANDAs. For its portion, Akorn, Inc. will receive $35 million in cash. Akorn-Strides LLC will continue to manufacture and distribute the approved products until April 30, 2011.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has completed enrollment in the first of two dose cohorts in its Phase 1 clinical trial of PV-10 for liver cancer, and that the therapy was very well tolerated by all three subjects treated, with substantial evidence of efficacy.
› Verified 3 days ago
Parit A Patel, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 737 N Michigan Ave Ste 1820, Chicago, IL 60611 Phone: 312-819-5338 Fax: 312-819-5337 | |
Akira Yamada, Plastic Surgery Medicare: Medicare Enrolled Practice Location: 225 E Chicago Ave, Division Of Plastic Surgery, Chicago, IL 60611 Phone: 312-227-6258 Fax: 312-227-9408 | |
Lyndsay Ann Kandi, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5841 S Maryland Ave # Mc6035, Chicago, IL 60637 Phone: 773-702-6302 Fax: 773-702-1634 | |
Dr. Diane L Gerber, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 250 E Pearson St, #2803, Chicago, IL 60611 Phone: 312-280-8707 | |
Stephanie Bond, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5841 S Maryland Ave # Mc6035, Chicago, IL 60637 Phone: 773-795-1240 | |
Anne Huang, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5841 S Maryland Ave # Mc6035, Chicago, IL 60637 Phone: 773-795-1240 Fax: 773-702-1634 | |
Maria Alexandra Artunduaga, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5841 S Maryland Ave, Mc 6035, Chicago, IL 60637 Phone: 773-795-1240 |